1. Home
  2. IMXI vs MYGN Comparison

IMXI vs MYGN Comparison

Compare IMXI & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo International Money Express Inc.

IMXI

International Money Express Inc.

HOLD

Current Price

$14.51

Market Cap

469.3M

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$5.98

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMXI
MYGN
Founded
1994
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
469.3M
444.2M
IPO Year
2016
1996

Fundamental Metrics

Financial Performance
Metric
IMXI
MYGN
Price
$14.51
$5.98
Analyst Decision
Buy
Buy
Analyst Count
2
7
Target Price
$15.00
$7.64
AVG Volume (30 Days)
451.5K
1.6M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.02
N/A
Revenue
$319,601,000.00
$771,400,000.00
Revenue This Year
$0.83
$6.86
Revenue Next Year
$1.49
$5.45
P/E Ratio
$727.00
N/A
Revenue Growth
16.68
2.33
52 Week Low
$8.58
$3.53
52 Week High
$15.95
$8.59

Technical Indicators

Market Signals
Indicator
IMXI
MYGN
Relative Strength Index (RSI) 47.77 73.10
Support Level $13.91 $4.29
Resistance Level $15.32 $7.29
Average True Range (ATR) 0.41 0.31
MACD 0.06 0.15
Stochastic Oscillator 69.83 93.27

Price Performance

Historical Comparison
IMXI
MYGN

About IMXI International Money Express Inc.

International Money Express Inc is an omnichannel money remittance services company focused on the United States of America to Latin America and the Caribbean corridor, which includes Mexico, Central and South America and the Caribbean. The company offers wire transfer, money order, Foreign exchange, and cash checking services, while the majority of the revenue is derived from wire transfer and money order fees. The firm's business is organized around one reportable segment that provides money remittance services between the U.S. and Canada to Mexico, Guatemala, and other countries in Latin America, Africa, and Asia.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: